Takeda Pharmaceutical Co's quarterly market cap
declined
from Jun. 2023 (円7,011,111 Mil) to Sep. 2023 (円6,903,116 Mil) and
declined
from Sep. 2023 (円6,903,116 Mil) to Dec. 2023 (円6,236,417 Mil).
Takeda Pharmaceutical Co's annual market cap
declined
from Mar. 2021 (円6,691,181 Mil) to Mar. 2022 (円5,435,241 Mil) but then
increased
from Mar. 2022 (円5,435,241 Mil) to Mar. 2023 (円6,637,843 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Takeda Pharmaceutical Co's Enterprise Value for Today is 円10,762,047 Mil.
Takeda Pharmaceutical Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Takeda Pharmaceutical Co's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Takeda Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Takeda Pharmaceutical Co's Market Cap falls into.
Takeda Pharmaceutical Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Takeda Pharmaceutical Co's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Takeda Pharmaceutical Co (SSE:4502) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Takeda Pharmaceutical Co Market Cap Related Terms
Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Takeda Pharmaceutical Co (SSE:4502) Business Description
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SSE:4502 has been successfully added to your 